Cryo-Cell International
CCEL
14 hedge funds and large institutions have $5.74M invested in Cryo-Cell International in 2024 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 2 closing their positions.
0.11% more ownership
Funds ownership: 11.07% → 11.18% (+0.11%)
0% more funds holding
Funds holding: 14 → 14 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
16% less capital invested
Capital invested by funds: $6.82M → $5.74M (-$1.08M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$112K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$4.27K |
| 4 |
BlackRock
New York
|
+$3.56K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.72K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RP
Rowlandmiller & Partners
Atlanta,
Georgia
|
-$110K |
| 2 |
Northern Trust
Chicago,
Illinois
|
-$2.5K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
-$165 |
| 5 |
Morgan Stanley
New York
|
-$7 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
HLA
1
Hamilton Lane Advisors
Conshohocken,
Pennsylvania
| $2.61M | – | – | – |
|
|
SA
2
SFI Advisors
Montclair,
New Jersey
| $1.05M | – | – | – |
|
|
3
Vanguard Group
Malvern,
Pennsylvania
| $744K | +$14.3K | +2,069 | +2% |
|
|
MPWT
4
MassMutual Private Wealth & Trust
Windsor,
Connecticut
| $707K | – | – | – |
|
|
5
Geode Capital Management
Boston,
Massachusetts
| $254K | +$112K | +16,203 | +68% |
|
|
6
Northern Trust
Chicago,
Illinois
| $139K | -$2.5K | -362 | -2% |
|
7
Cerity Partners
New York
| $125K | – | – | – |
|
|
8
BlackRock
New York
| $87K | +$3.56K | +516 | +4% |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $12.7K | – | – | – |
|
|
TRCT
10
Tower Research Capital (TRC)
New York
| $3.94K | +$4.27K | +619 | New |
|
|
11
Morgan Stanley
New York
| $3.82K | -$7 | -1 | -0.2% |
|
|
12
UBS Group
Zurich,
Switzerland
| $1.59K | +$1.72K | +249 | New |
|
|
13
Bank of America
Charlotte,
North Carolina
| $210 | -$165 | -24 | -42% |
|
14
JP Morgan Chase
New York
| $70 | – | – | – |
|
|
RP
15
Rowlandmiller & Partners
Atlanta,
Georgia
| – | -$110K | -14,433 | Closed |
|
|
16
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1K | -121 | Closed |
|
CCEL Hedge Fund Activity: Q3 2024 in Review
14 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Cryo-Cell International (CCEL) for Q3 2024, worth a combined $5.74M — down 16% from $6.82M a quarter earlier.
Fund positioning in CCEL was balanced in Q3 2024: 2 funds opened new positions, 2 closed out, 3 added to existing stakes and 3 trimmed.
The largest buyer was Geode Capital Management, adding an estimated $112K. The largest seller was Rowlandmiller & Partners, exiting entirely with an estimated $110K sold.
- 14 institutional investors held Cryo-Cell International (CCEL) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $5.74M of Cryo-Cell International stock for Q3 2024, down 16% quarter-over-quarter.
- 2 funds opened new Cryo-Cell International positions in Q3 2024 and 2 closed out, a net change of 0 holders.
- The largest Cryo-Cell International buyer in Q3 2024 was Geode Capital Management, an estimated $112K added.
- The largest Cryo-Cell International seller in Q3 2024 was Rowlandmiller & Partners, an estimated $110K sold.
Based on aggregated 13F filings for Q3 2024.